ABSTRACT CHEF/18 is a diploid Chinese hamster cell line ofembryonic origin, which is fibroblastic in structure, but behaves like a mesenchymal stem cell line in its ability to differentiate into adipocytes, myoblasts, and chondrocytes. With these cells, adipocyte formation has been divided experimentally into two stages: (i) determination of pre-adipocytes, which have lost the ability to form other cell types while retaining their fibroblast structure; and (ii) commitment or terminal differentiation, in which lipids accumulate, adipocyte structure develops, and cells lose the ability to divide. This paper reports that the first stage can be induced by exposure to 5-azacytidine or 2'-deoxy-5-azacytidine, drugs that also induce CHEF cells to form other mesenchymal cell types, or by growth with added insulin. Pre-adipocytes are distinguished from CHEF stem cells by (i) their inability to form other mesenchymal cell types; and (ii) their rapid accumulation of lipid in response to added insulin. The possibility is discussed that both insulin and the cytidine analogs promote differentiation by the same mechanism, namely changes in the pattern of DNA methylation. Do changes at the DNA level mediate cellular differentiation? Recent studies describing the multipotentiality of embryonic fibroblastic cell lines have provided novel material with which to examine this question. The ability of ageing 3T3 cells occasionally to undergo conversion to adipocytes was described by Green and colleagues (1-4). Subsequently, Jones and colleagues (5) (6) (7) (8) found that the cytidine analogs azacytidine and deoxyazacytidine could mediate this conversion of3T3 cells to adipocytes as well as the differentiation.of a different embryonic mouse fibroblastic cell line, lOT 1/2 (9), to form not only adipocytes but also myoblasts and chondrocytes. Jones and Taylor proposed that the cytidine analogs act by interfering with methylation after incorporation into newly replicated DNA (8).
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The possibility that changes in DNA methylation might be involved in differentiation was proposed by Scarano (10) . Subsequently, the discovery of site-specific methylation and restriction enzymes (11, 12) as well as improved methods for detection of methylated bases (12) has made it experimentally feasible to examine changes in methylation associated with defined steps in differentiation. Hypomethylation has been reported in differentiation of Friend erythroleukemia cells (13, 14) and in chemically induced and spontaneous hepatomas (15, 16) . In the microbial eukaryotic alga Chlamydomonas methylation during gametogenesis and zygote development has been shown to protect chloroplast DNA ofmaternal origin against the restriction and degradation by endonucleases of paternal homologous DNA that occurs in zygotes and is the molecular basis of maternal inheritance of chloroplast genes (17) (18) (19) (20) .
These changes are large scale and can be measured analytically. Changes in methylation have also been reported at the level of single recognition sites in DNA; the predominant pattern is decreased methylation of particular sites in genes being transcribed and increased methylation associated with nontranscription (21, 22) . The respective functions and regulation of paired methylation-restriction and of methylation per se in eukaryotic gene expression remain almost totally unknown.
This paper describes the differentiation in cell culture of a secondary mesenchymal stem cell line with a fibroblastic structure to form myoblasts, chondrocytes, and adipocytes. This stem cell line, consisting ofa twice-cloned population ofdiploid Chinese hamster embryonic fibroblasts called CHEF/18, has previously been studied extensively in this laboratory (23) (24) (25) (26) . CHEF/18 cells are nontumorigenic and unique in their diploidy and chromosomal stability, which confer a high degree of phenotypic and genetic homogeneity. The conversion of these cells into terminally differentiated mesenchymal derivatives as described below can be induced by exposure to 5-azacytidine (azaCyd) for a single cell cycle. Further, we have discovered that in the absence of azacytidine growth with added insulin alone can convert these stem cells almost 100% to pre-adipocytes. We show that the adipocyte conversion occurs in two separable stages, each induced by insulin. The second stage, from preadipocytes to terminally differentiated adipocytes, has previously been shown with 3T3 cells to respond to insulin (3) as well as to other agents (27) , but the first stage, from stem cells to preadipocytes, has not been previously described in detail, and the role of insulin in this process has not previously been reported. This stage is an important step in embryonic determination (28) .
MATERIALS AND METHODS CHEF cells were grown and maintained as described (23) on plastic in a minimal essential medium (Kansas City Biological, Kansas City, MO) plus 5% or 10% fetal calf serum (Microbiological Associates, Bethesda, MD) plus antibiotics (penicillin at 100 units/ml and streptomycin at 100 jig/ml) in a humidified incubator with 6.5% CO2 at 370C. Cells were passed in T-25 flasks (Corning) and plated in 60-mm (Falcon) and 100-mm (Lux Scientific) dishes. Chondrocytes and myoblasts were identified by morphology. To identify adipocytes, cells attached to plastic were fixed with formalin, stained with oil red 0 (1-4), and counterstained with hematoxylin. Chromosomes were analyzed by trypsin/Giemsa banding as described (25) . azaCyd was obtained from Sigma; 2'-deoxy-5-azacytidine (dazaCyd) was a gift from Howard Green; bovine insulin was from Sigma. No colonies were seen that consisted entirely of lipid-accumulating cells, but rather lipid accumulation was confined principally to sectors (see Fig. 1 Green and Kehinde (4).
RESULTS

Multiple
The most important observation is that a similar number of adipocyte-containing colonies were found whether or not the cells had been pretreated with azacytidine, provided they had been grown with insulin. This result provides evidence that insulin alone, in the absence of azaCyd, is effective in the adipocyte differentiation of CHEF/18 cells.
The experiment summarized in Table 1 Comparison ofCHEF/18 with Pre-adipocyte Cultures. Preadipocyte cultures were established by picking fat-cell containing regions from confluent cultures of CHEF/18 cells grown with insulin either treated with azaCyd or untreated. Cell lines IV/1 and IV/2 were derived from azaCyd-treated cells, whereas 11/2 came from an azaCyd-untreated culture grown initially with insulin but not terminally differentiated. All three cell lines will grow indefinitely in the absence ofinsulin but undergo terminal differentiation in its presence. The rate of fat accumulation in response to added insulin was examined in experiments similar to those described above.
Cells ofCHEF/18 and the three pre-adipocyte lines growing exponentially on regular medium without added insulin were used as inocula, and plated at 103 cells per dish. Insulin was added after 7, 14, or 21 days, and plates were sampled for fixation and staining at 3 and 7 days after insulin was added. As shown in Table 2 , the pre-adipocyte lines were readily distinguishable from CHEF/18 in this assay. Seven-day cultures to which insulin was added for a second 7 days showed substantial sectors ofround fat-containing cells in about half the final number of such colonies, whereas the first similar colonies were found in CHEF/18 cultures at 21 days (14 + 7). Not shown in Table 2 is the further qualitative difference between CHEF/ 18 and the pre-adipocyte cultures, which could be seen at a glance. CHEF/18 colonies contained far fewer fat-containing cells at 21 + 7 days than did the PA colonies at 7 + 7 or 14 + 7 days. Thus, the kinetics ofappearance ofrounded, fat-globule-containing cells in response to insulin is dramatically and reproducibly different in CHEF/18 and in pre-adipocyte cells.
The pre-adipocyte cell line that was not treated with azaCyd differed (II/2) from the azaCyd-treated lines (IV/1 and IV/2) in the slowness of its response to insulin after 14 or 21 days growth in a medium. Whether this slow response is characteristic of insulin-induced pre-adipocytes is not yet known. Chromosomes. Chromosomes of the three pre-adipocyte lines in Table 2 were examined by Giemsa banding and compared with the CHEF/18 cells previously described (25) . The IV/1 and IV/2 lines were indistinguishable from CHEF/18, whereas the 11/2 cells were similar except for an extra chromosome 3p present in some cells. DISCUSSION This paper reports that CHEF/18, the Chinese hamster embryo fibroblastic cell line (23) (24) (25) (26) , behaves very much like a secondary mesenchymal stem cell line, capable of differentiating into adipocytes, myoblasts, or chondrocytes. In the adipocyte conversion, two stages have been distinguished in this work: stage I, called determination, in which the multipotentiality of the stem cells becomes limited to the adipocyte pathway; and stage II, called commitment, in which the pre-adipocytes undergo terminal differentiation mediated by insulin. Biochemistry of the stage II process is being investigated in several laboratories (27, 29, 30) . The stage I process has not been previously examined in detail.
We have found that the stage I process can be activated by exposure ofthe cells to azaCyd or dazaCyd for a single cell cycle or by growing the stem cells for 3-4 weeks with added insulin. The products ofthe stage I process, whether induced by azaCyd or by insulin, are pre-adipocytes, which are not yet terminally differentiated and can be grown indefinitely in culture in the absence of added insulin.
Are CHEF/18 cells in fact pre-adipocytes? The answer is clearly no, for several reasons.
(i) CHEF/18 cells are a clonal diploid population and therefore genetically uniform. Under optimal conditions, virtually every colony-forming cell can give rise to a colony containing adipocytes. Thus, adipocyte differentiation is not a selection process at the cellular level. Nonetheless, under different conditions CHEF/18 cells can give rise to other mesenchymal cell types.
(ii) CHEF/18 cells can give rise to several differentiated cell types, whereas pre-adipocytes have only two options: either to grow as such in the absence of added insulin or to terminally differentiate in its presence. In experiments designed to test this point, pre-adipocyte cultures were treated with azaCyd. No other differentiated cell types were detected.
(iii) Pre-adipocytes grown without added insulin resemble CHEF/18 stem cells morphologically. They can be distinguished operationally by the kinetics of their response to insulin. (see Table 2) The stage II process, as studied with 3T3-L1 pre-adipocytes (2), can be induced not only by insulin but also by a variety of other agents, of which an effective combination is the glucocorticoid dexamethasone plus 3-isobutyl-1-methylxanthine, an inhibitor of cAMP phosphodiesterase (27) . Spiegelman and Green (29) have described changes in the rates of synthesis of several proteins occurring during adipose conversion of 3T3-derived pre-adipocytes, and they have shown that the changes are regulated by the amounts of translatable mRNAs and furthermore that mRNA availability is itself noncoordinately regulated for various ofthe conversion-related proteins. Rosen and Cell Biology: Sager and Kovac colleagues (31, 32) have described an insulin-induced phosphorylation of ribosomal protein S6 that occurs during conversion of 3T3-LI cells. Both findings indicate the complex nature of the stage II process.
Is the stage I process also complex, and can it be induced by agents other than azaCyd or insulin? As presently understood, insulin has two distinct sets of actions, the metabolic activities exemplified by glucose oxidation, and the growth-promoting activities, seen as promotion of DNA replication and cell division (33) . In general, the metabolic activities respond to insulin concentrations about 1/1000th of those required for growth promotion. Growth promotion may be mediated by one of a family of insulin-like polypeptides, the somatomedins (34) , through a different set of receptors than those that bind insulin with high affinity. It is clearly important to distinguish whether the stage I effect on differentiation described in this paper is mediated more effectively by insulin or by an insulin-like factor. Adipose conversion was originally described by Green and coworkers (1) (2) (3) (4) Fig. 1 .
Our pre-adipocyte clones respond to added insulin with different patterns of adipose conversion. Clones such as IV/1 respond rapidly, as shown in Table 2 , and, when plated at 50 or 100 cells per plate, each plating unit undergoes conversion (data not shown). Clone IV/2 responds somewhat more slowly than IV/1, and clone II/2 is even slower, with fewer colonies forming adipose cells within a given time-i. e., 4 weeks. These clonal differences in time and frequency of adipocyte conversion (or commitment) are reproducible on subculture. A myogenic clonal cell derived from a mouse teratocarcinoma (35) has been shown to give rise to subclones that differentiate into adipocytes and fibroblasts as well as to myoblasts, and separate subclones show heritable differences in which cell type is predominant (36) . These clonal differences are analogous to those we have described in this paper.
The arrangement of terminally differentiating adipocytes in pre-adipocyte colonies (Fig. 1) (8) . Similarly, decreased methylation has been observed in Friend erythroleukemia cells after differentiation induced in cell culture (13, 14) . Regulated changes in methylation could provide a metabolic switch, as suggested also by the evidence that links transcription with the loss of methylation at specific sites in DNA (21, 22) . Because insulin mediates the stage I conversion of CHEF/18 stem cells to pre-adipocytes as effectively as does azacytidine or deoxyazacytidine, it is a fair inference that insulin itselfmay act directly or indirectly by affecting DNA methylation.
